Search research articles
Contact Us
Filters
Showing results (41-50 of 86) with videos related to
Page
of 9
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja
|
September 21, 2002
[A vaccine against papillomavirus infections and cancer]
Matti Lehtinen, Dan Apter, Riitta Heikkilä, et al.
Journal of Clinical Medicine
|
December 30, 2025
Multicentre Trial Evaluating the Safety and Tolerability of Estetrol-Drospirenone Combined Oral Contraceptive in Postmenarchal Female Adolescents
Angelica Lindén Hirschberg, Lali Pkhaladze, Kristina Gemzell-Danielsson, et al.
Contraception
|
May 8, 2016
Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA)
Dan Apter, Yvette Zimmerman, Louise Beekman, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception
|
June 23, 2017
Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control
Dan Apter, Yvette Zimmerman, Louise Beekman, et al.
International Journal of Cancer
|
December 28, 2017
Vaccination protects against invasive HPV-associated cancers
Tapio Luostarinen, Dan Apter, Joakim Dillner, et al.
Plos One
|
September 7, 2013
Impact of vaccination on 14 high-risk HPV type infections: a mathematical modelling approach
Simopekka Vänskä, Kari Auranen, Tuija Leino, et al.
Duodecim; Laaketieteellinen Aikakauskirja
|
November 10, 2006
[Not Available]
Elise Kosunen, Niilo Ala-Fossi, Sirkkha-Liisa Ala-Fossi, et al.
International Journal of Cancer
|
November 27, 2012
Understanding long-term protection of human papillomavirus vaccination against cervical carcinoma: Cancer registry-based follow-up
Muhammad Mohsin Rana, Heini Huhtala, Dan Apter, et al.
Human Vaccines & Immunotherapeutics
|
December 13, 2019
Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12-15 years: end-of-study results from a community-randomized study up to 6.5 years
Dan Bi, Dan Apter, Tiina Eriksson, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception
|
June 18, 2013
Impact of HPV16/18 vaccination on quality of life: a pilot study
Tiina Eriksson, Saku Torvinen, Sarah C Woodhall, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 86) with videos related to
Sort By:
Page
of 9
Duodecim; Laaketieteellinen Aikakauskirja
|
September 21, 2002
[A vaccine against papillomavirus infections and cancer]
Matti Lehtinen, Dan Apter, Riitta Heikkilä, et al.
Journal of Clinical Medicine
|
December 30, 2025
Multicentre Trial Evaluating the Safety and Tolerability of Estetrol-Drospirenone Combined Oral Contraceptive in Postmenarchal Female Adolescents
Angelica Lindén Hirschberg, Lali Pkhaladze, Kristina Gemzell-Danielsson, et al.
Contraception
|
May 8, 2016
Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA)
Dan Apter, Yvette Zimmerman, Louise Beekman, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception
|
June 23, 2017
Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control
Dan Apter, Yvette Zimmerman, Louise Beekman, et al.
International Journal of Cancer
|
December 28, 2017
Vaccination protects against invasive HPV-associated cancers
Tapio Luostarinen, Dan Apter, Joakim Dillner, et al.
Plos One
|
September 7, 2013
Impact of vaccination on 14 high-risk HPV type infections: a mathematical modelling approach
Simopekka Vänskä, Kari Auranen, Tuija Leino, et al.
Duodecim; Laaketieteellinen Aikakauskirja
|
November 10, 2006
[Not Available]
Elise Kosunen, Niilo Ala-Fossi, Sirkkha-Liisa Ala-Fossi, et al.
International Journal of Cancer
|
November 27, 2012
Understanding long-term protection of human papillomavirus vaccination against cervical carcinoma: Cancer registry-based follow-up
Muhammad Mohsin Rana, Heini Huhtala, Dan Apter, et al.
Human Vaccines & Immunotherapeutics
|
December 13, 2019
Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12-15 years: end-of-study results from a community-randomized study up to 6.5 years
Dan Bi, Dan Apter, Tiina Eriksson, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception
|
June 18, 2013
Impact of HPV16/18 vaccination on quality of life: a pilot study
Tiina Eriksson, Saku Torvinen, Sarah C Woodhall, et al.
Page
of 9